Back
Protagonist Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
PTGX
Sponsored
Multimillionaire Trader Reveals His #1 Gold Pick
Click here to learn more about this game-changing opportunity.
Buy
56
PTGX
Protagonist Therapeutics
Last Price:
47.64
Seasonality Move:
13.55%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the Ultimate Gold Play: $20 for a 1 Oz Stake in Gold!
Don't miss out-click here for urgent details on the #1 gold play of the year!Protagonist Therapeutics Price Quote
$47.64
Protagonist Therapeutics Key Stats
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Day range:
$46.59 - $48.32
52-week range:
$13.72 - $48.32
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.18%
Volume:
598.5K
Avg. volume:
685.7K
1-year change:
208.55%
Market cap:
$2.8B
Revenue:
$60M
EPS:
$2.62
How Much Does Protagonist Therapeutics Make?
Data Unavailable
Is Protagonist Therapeutics Growing As A Company?
Data Unavailable
Protagonist Therapeutics Stock Price Performance
-
Did Protagonist Therapeutics Stock Go Up Last Month?
Protagonist Therapeutics share price went up by 1.32% last month -
Did PTGX's Share Price Rise Over The Last Year?
PTGX share price rose by 208.55% over the past 1 year
What Is Protagonist Therapeutics 52-Week High & Low?
-
What Is Protagonist Therapeutics’s 52-Week High Share Price?
Protagonist Therapeutics has traded as high as $48.32 over the past 52 weeks -
What Is Protagonist Therapeutics’s 52-Week Low Share Price?
Protagonist Therapeutics has traded as low as $13.72 over the past 52 weeks
Protagonist Therapeutics Price To Free Cash Flow
-
Is Protagonist Therapeutics Stock Overvalued?
Protagonist Therapeutics is trading at a price to free cash flow ratio of 12.61 -
Is Protagonist Therapeutics Stock Undervalued?
Protagonist Therapeutics EV to Free Cash Flow ratio is 9.71 -
What Is Protagonist Therapeutics’s Price Earnings Growth Ratio?
PTGX PEG ratio is 0.00 -
Is Protagonist Therapeutics Trading At A Premium To Earnings?
Protagonist Therapeutics EV to EBIT ratio is 14.73
Is It Risky To Buy Protagonist Therapeutics?
-
How Much Debt Does Protagonist Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Protagonist Therapeutics Have?
Cash and short term investments quarterly total is $564M -
What Is Protagonist Therapeutics’s Book Value Per Share?
Book value per share is 9.21
Is Protagonist Therapeutics Cash Flow Positive?
-
What Is PTGX Cash Flow From Operations?
Cash flow from operations (TTM) is $231.5M -
What Is Protagonist Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $45.6M -
What Is Protagonist Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$156.9M
Protagonist Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
PTGX return on invested capital is 41.77% -
What Is Protagonist Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 37.73% -
What Is PTGX Return On Equity?
ROE is a measure of profitability and is 41.77%
Protagonist Therapeutics Earnings Date & Stock Price
-
What Is Protagonist Therapeutics's Stock Price Today?
A single share of PTGX can be purchased today for 47.64 -
What Is Protagonist Therapeutics’s Stock Symbol?
Protagonist Therapeutics trades on the nasdaq under the ticker symbol: PTGX -
When Is Protagonist Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Protagonist Therapeutics is scheduled on November 1, 2024 -
When Is PTGX's next ex-dividend date?
Protagonist Therapeutics's next ex-dividend date is October 16, 2024 -
How To Buy Protagonist Therapeutics Stock?
You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Protagonist Therapeutics Competitors
-
Who Are Protagonist Therapeutics's Competitors?
Below is a list of companies who compete with Protagonist Therapeutics or are related in some way:
Protagonist Therapeutics Dividend Yield
-
What Is PTGX Dividend Yield?
Protagonist Therapeutics’s dividend yield currently is 0% -
What Is Protagonist Therapeutics’s Payout Ratio?
Protagonist Therapeutics’s payout ratio is 0% -
When Did Protagonist Therapeutics Last Pay A Dividend?
The latest dividend pay date is October 16, 2024 -
What Is Protagonist Therapeutics’s Dividend Per Share?
Protagonist Therapeutics pays a dividend of $0.00 per share
Protagonist Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -21.11% |
Revenue: | 0% | -37.5% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 52.13 |
Upside from Last Price: | 9.41% |